Proof of positive impact of CGM for diabetics on injections
The DIaMonD study (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) is the first-of-its-kind study that demonstrates the impact of CGM on A1C and
The DIaMonD study (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) is the first-of-its-kind study that demonstrates the impact of CGM on A1C and
At the moment in the UK, the FreeStyle Libre system from Abbott is available to purchase online by interested diabetics and is also being used
Stephanie Haack (pictured) was diagnosed with T1D seven years ago and to a great extent was self-diagnosed, thanks to the internet. She says, “I Googled
Pharmaceutical and medical technology company Abbott recently hosted an event in Stockholm for a gathering of European bloggers, many of whom were sporting one of
Nemaura Medical, based in Loughborough, UK, received European regulatory (CE) approval, and following improvements to the user interface and reduction in size of the device,
Our latest issue takes a look at pumpwear from Sweden thanks to AnnaPS. There’s fun Libre sensor stickers from Pep Me Up, as well as
The Eversense Continuous Glucose Monitoring (CGM) System from Senseonics has been granted an EU CE mark approval. An implantable and long-term glucose sensor, the Eversense
Medtronic is to work with Qualcomm Life to develop a new generation of smaller, affordable continuous glucose monitors (CGMs) for people with Type 2 diabetes
February 2016: NICE has developed a medtech innovation briefing (MIB) on MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type
Abbott’s web-shop is now open to new customers. You can now order up to 6 FreeStyle Libre sensors at a time. The easy-to-wear sensors give